127 200

Cited 106 times in

DNA methylation predicts recurrence from resected stage III proximal colon cancer

DC FieldValueLanguage
dc.contributor.author정현철-
dc.contributor.author김남규-
dc.contributor.author신상준-
dc.contributor.author안중배-
dc.date.accessioned2014-12-20T17:49:34Z-
dc.date.available2014-12-20T17:49:34Z-
dc.date.issued2011-
dc.identifier.issn0008-543X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/95326-
dc.description.abstractBACKGROUND: In colorectal cancer (CRC), DNA methylation anomalies define distinct subgroups termed CpG island methylator phenotype 1 (CIMP1), CIMP2, and CIMP-negative. The role of this classification in predicting recurrence and disease-free survival (DFS) in resected stage III CRC was evaluated. METHODS: Sporadic cancers from 161 patients were analyzed. Bisulfite pyrosequencing was used to examine the methylation of 2 global DNA methylation markers (LINE-1, Alu) and 9 loci (MINT1, MINT2, MINT31, P16, hMLH1, P14, SFRP1, SFRP2, and WNT5A). Mutations in BRAF and KRAS were assayed. RESULTS: Gene hypermethylation clustered in discrete groups of patients, indicating the presence of CIMP. K-means clustering analysis identified 3 discrete subgroups: CIMP1 (n = 22, 13.7%), associated with proximal location and BRAF mutations; CIMP2 (n = 40, 24.8%), associated with KRAS mutations; and CIMP-negative (n = 99, 61.5%), associated with distal location. In proximal CRC, CIMP1 was correlated with a higher recurrence rate (53% for CIMP1, 18% for CIMP2, and 26% for CIMP-negative) and a worse DFS (P = .015). Also in proximal CRC, LINE-1 methylation was lower in patients whose cancer recurred compared with those whose cancer did not recur (P = .049). In multivariate analysis, CIMP1 and low LINE1 methylation were independent prognostic factors for DFS in proximal CRC (P = .008 for classification by K-means clustering analysis; P = .040 for LINE-1 methylation status). CONCLUSIONS: DNA methylation is a useful biomarker of recurrence in resected stage III proximal but not distal CRC. However, as the number of CIMP1 cases was small in distal CRC, further study is required to validate our findings.-
dc.description.statementOfResponsibilityopen-
dc.format.extent1847~1854-
dc.relation.isPartOfCancer-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAged, 80 and over-
dc.subject.MESHColonic Neoplasms/genetics*-
dc.subject.MESHColonic Neoplasms/mortality-
dc.subject.MESHColonic Neoplasms/pathology*-
dc.subject.MESHDNA Methylation*-
dc.subject.MESHDisease-Free Survival-
dc.subject.MESHFemale-
dc.subject.MESHGenetic Markers-
dc.subject.MESHHumans-
dc.subject.MESHMale-
dc.subject.MESHMicrosatellite Instability-
dc.subject.MESHMiddle Aged-
dc.subject.MESHMutation-
dc.subject.MESHPromoter Regions, Genetic-
dc.subject.MESHProto-Oncogene Proteins/genetics*-
dc.subject.MESHProto-Oncogene Proteins B-raf/genetics*-
dc.subject.MESHProto-Oncogene Proteins p21(ras)-
dc.subject.MESHRecurrence-
dc.subject.MESHras Proteins/genetics*-
dc.titleDNA methylation predicts recurrence from resected stage III proximal colon cancer-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Surgery (외과학)-
dc.contributor.googleauthorJoong Bae Ahn-
dc.contributor.googleauthorWoon Bok Chung-
dc.contributor.googleauthorOsamu Maeda-
dc.contributor.googleauthorSang Joon Shin-
dc.contributor.googleauthorHyun Soo Kim-
dc.contributor.googleauthorHyun Chul Chung-
dc.contributor.googleauthorNam Kyu Kim-
dc.contributor.googleauthorJean-Pierre J. Issa-
dc.identifier.doi10.1002/cncr.25737-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA03773-
dc.contributor.localIdA00353-
dc.contributor.localIdA02105-
dc.contributor.localIdA02262-
dc.relation.journalcodeJ00434-
dc.identifier.pmid21509761-
dc.subject.keywordcolon cancer-
dc.subject.keywordCpG island methylator phenotype-
dc.subject.keywordLINE-1-
dc.subject.keywordmethylation biomarker-
dc.contributor.alternativeNameChung, Hyun Cheol-
dc.contributor.alternativeNameKim, Nam Kyu-
dc.contributor.alternativeNameShin, Sang Joon-
dc.contributor.alternativeNameAhn, Joong Bae-
dc.contributor.affiliatedAuthorChung, Hyun Cheol-
dc.contributor.affiliatedAuthorKim, Nam Kyu-
dc.contributor.affiliatedAuthorShin, Sang Joon-
dc.contributor.affiliatedAuthorAhn, Joong Bae-
dc.rights.accessRightsfree-
dc.citation.volume117-
dc.citation.number9-
dc.citation.startPage1847-
dc.citation.endPage1854-
dc.identifier.bibliographicCitationCancer, Vol.117(9) : 1847-1854, 2011-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.